Informační systém MU
VALÁŠKOVÁ, Iveta, Jitka KADLECOVÁ, Petr KUGLÍK, Iva SLÁMOVÁ and Renata GAILLYOVÁ. Our first experience in preimplantation genetic diagnosis. In European Journal of Human Genetics. Praha: Nature Publishing Group, 2005, p. 268. ISBN 1018-4813.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Our first experience in preimplantation genetic diagnosis.
Name in Czech Naše první zkušenosti s preimplantační genetickou diagnostikou
Authors VALÁŠKOVÁ, Iveta (203 Czech Republic), Jitka KADLECOVÁ (203 Czech Republic), Petr KUGLÍK (203 Czech Republic, guarantor), Iva SLÁMOVÁ (203 Czech Republic) and Renata GAILLYOVÁ (203 Czech Republic).
Edition Praha, European Journal of Human Genetics, p. 268-268, 2005.
Publisher Nature Publishing Group
Other information
Original language English
Type of outcome Proceedings paper
Field of Study Biotechnology and bionics
Country of publisher Czech Republic
Confidentiality degree is not subject to a state or trade secret
RIV identification code RIV/00216224:14310/05:00014636
Organization unit Faculty of Science
ISBN 1018-4813
Keywords in English PGD; chromosomal aberrations; FISH; PCR; cystic fibrosis
Tags chromosomal aberrations, cystic fibrosis, FISH, PCR, PGD
Changed by Changed by: doc. RNDr. Petr Kuglík, CSc., učo 1881. Changed: 18/1/2007 13:57.
Abstract
Prevention of the birth of affected children in couples at risk for transmitting a genetic disorder is currently based on population screening and prenatal diagnosis, followed by termination of affected pregnancies. However, this is the most sensitive problem in the control of genetic disease, which is incompatible with life or not tolerated in populations and ethnic groups. Preimplantation genetic diagnosis (PGD) is a principally new approach for the prevention of genetic disorders, which allows the selection of unaffected IVF embryos for establishing pregnancies in couples at risk. PGD may be achieved by testing female gametes (polar body analysis), blastomeres from cleavage stage embryos, or blastocysts. PGD can be applied for monogenic disorders or chromosomal abnormalities, using diagnostic protocols based on the polymerase chain reaction (PCR) or fluorescence in situ hybridisation (FISH), respectively. Our genetic centre at present concentrates on chromosomal abnormalities, while also on genotyping for single-gene disorders. Genetic analyses are performed on biopsied blastomeres . PGD of chromosomal abnormalities is applied in patients with repeated IVF failures or spontaneous abortions. This application is essentially a screening procedure to detect aneuploidies/polyploidies or translocations most commonly observed postnatally or in spontaneus abortions. We optimise the first PCR based PGD protocol for genotyping of Cystic Fibrosis Transmembrane Regulator (CFTR) gene with focusing on several inherent difficulties associated with single cell DNA amplifications including potential sample contamination, total PCR failure and allelic drop out. These difficulties should be minimised for any PGD PCR protocol before clinical application.
Abstract (in Czech)
Práce se zabývá prvními zkušenostmi pracoviště OLG FN Brno a Laboratoře molekulární cytogenetiky PřF MU s preimplantační genetickou diagnostikou při vyšetřování početních i strukturních chromozomových abnormalit a některých monogenních onemocnění (cystická fibróza).
Links
MSM0021622415, plan (intention)Name: Molekulární podstata buněčných a tkáňových regulací
Investor: Ministry of Education, Youth and Sports of the CR, Molecular basis of cell and tissue regulations
Displayed: 24/7/2024 18:19